Life Sciences Industry Extra: Federal Funding Opportunity for Orphan Products


As part of its ongoing effort to support the development of orphan products, the Food and Drug Administration (FDA) announced the availability of research grants for up to $400,000 per year for FY 2010 and FY 2011. These grants are available to support clinical research programs for drugs, biologics, medical devices (including diagnostics), and foods for medical purposes that are indicated for a disease or condition that affects fewer than 200,000 people in the United States, and for which no current therapy exists or the proposed product will be superior to the existing product. A diagnostic or a vaccine will qualify for orphan status if the U.S. population to which it will be administered is no more than 200,000 people per year.

Please see full report for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin | Attorney Advertising

Written by:


Mintz Levin on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.